药明巨诺-B午后涨近9% CAR-T产品瑞基奥仑赛在中国澳门获批上市

智通财经
12 Jun

药明巨诺-b(02126)午后涨近9%,截至发稿,涨6.67%,报2.4港元,成交额1295.59万港元。消息面上,药明巨诺近日宣布,瑞基奥仑赛注射液的新药上市许可申请(NDA)获得中国澳门药物监督管理局批准。瑞基奥仑赛注射液是药明巨诺在巨诺医疗(百时美施贵宝旗下的公司)的CAR-T细胞工艺平台的基础上,自主开发的一款靶向CD19的自体CAR-T细胞免疫治疗产品。据悉,本次获批复盖三大适应症,包括...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10